BRIEF published on 06/10/2026 at 07:35, 4 months 16 days ago Sensorion Refocuses on SENS-601 for Gene Therapy Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF published on 06/10/2026 at 07:35, 4 months 16 days ago Sensorion se Recentre sur SENS-601 pour la Thérapie Génique Essais Cliniques Thérapie Génique Sensorion Perte Auditive SENS-601
BRIEF published on 06/10/2026 at 07:35, 4 months 16 days ago Sensorion Advances SENS-601 for GJB2-Related Hearing Loss Clinical Trials Gene Therapy Sensorion SENS-601 GJB2 Hearing Loss
BRIEF published on 06/10/2026 at 07:35, 4 months 16 days ago Sensorion Advances SENS-601 pour la perte auditive liée au gène GJB2 Essais Cliniques Thérapie Génique Sensorion SENS-601 Perte Auditive GJB2
PRESS RELEASE published on 06/10/2026 at 07:30, 4 months 16 days ago Informations privilégiées / Autres communiqués Sensorion franchit des étapes réglementaires clés pour SENS-601 dans la perte auditive liée au gène GJB2 et le sélectionne comme principal candidat-médicament en thérapie génique Thérapie Génique Sensorion Perte Auditive SENS-601 Gène GJB2
PRESS RELEASE published on 06/10/2026 at 07:30, 4 months 16 days ago Inside Information / Other news releases Sensorion achieves key regulatory milestones for SENS-601 addressing GJB2-related hearing loss and discontinues SENS-501. Fast Track procedure granted by ANSM in France. Clinical trials planned in Canada and U.S. IND submission targeted by 2026 Clinical Trials Gene Therapy Sensorion Regulatory Milestones GJB2-related Hearing Loss
BRIEF published on 05/18/2026 at 07:35, 5 months 8 days ago Sensorion nomme Fred Chereau au poste de PDG Biotechnologie Thérapie Génique Nomination Du PDG Sensorion Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 5 months 8 days ago Fred Chereau nommé Directeur Général de Sensorion Direction Générale Thérapie Génique Sensorion Fred Chereau Pertes D'audition
BRIEF published on 05/18/2026 at 07:35, 5 months 8 days ago Fred Chereau appointed Managing Director of Sensorion Gene Therapy General Management Hearing Loss Sensory Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 5 months 8 days ago Sensorion Appoints Fred Chereau as CEO Biotechnology CEO Appointment Gene Therapy Sensorion Fred Chereau
Published on 10/27/2026 at 01:00, 6 hours 16 minutes ago Mining Exploration Entity or Oil and Gas Exploration Entity Quarterly Cash Flow Report
Published on 10/27/2026 at 00:10, 7 hours 6 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:30, 7 hours 46 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:00, 8 hours 16 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 9 hours 16 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/27/2026 at 07:00, 15 minutes ago INFICON reports record third quarter 2026 and raises full-year guidance
Published on 10/27/2026 at 07:00, 15 minutes ago REINET INVESTMENTS S.C.A. SHARE BUYBACK PROGRAMME – UPDATE 27 October 2026
Published on 10/27/2026 at 07:00, 15 minutes ago SIG Group AG: SIG delivers solid growth and higher profitability, and raises full-year margin guidance
Published on 10/27/2026 at 07:00, 15 minutes ago SIG Group AG: SIG outlines roadmap to accelerate profitable growth, expand margins and increase shareholder returns
Published on 10/26/2026 at 18:11, 13 hours 5 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 13 hours 5 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 13 hours 31 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 13 hours 31 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
